Matthew T. Chang

2014–2023 年に発表

38
論文数
18,566
被引用数
34
h 指数
38
i10 指数

被引用数

Matthew T. Chang の年別被引用数1992 年: 被引用 2 件1998 年: 被引用 1 件2000 年: 被引用 1 件2004 年: 被引用 4 件2005 年: 被引用 1 件2007 年: 被引用 2 件2009 年: 被引用 1 件2013 年: 被引用 2 件2014 年: 被引用 1 件2015 年: 被引用 10 件2016 年: 被引用 65 件2017 年: 被引用 206 件2018 年: 被引用 431 件2019 年: 被引用 1,180 件2020 年: 被引用 1,457 件2021 年: 被引用 1,394 件2022 年: 被引用 1,072 件2023 年: 被引用 789 件2024 年: 被引用 1,168 件2025 年: 被引用 527 件2026 年: 被引用 24 件1993〜1997 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません2001〜2003 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません2008 年は被引用が無いため表示していません2010〜2012 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,796 件、この内訳の 30.6%中国: 引用元論文 1,289 件、この内訳の 10.4%イギリス: 引用元論文 825 件、この内訳の 6.7%ドイツ: 引用元論文 613 件、この内訳の 4.9%イタリア: 引用元論文 590 件、この内訳の 4.8%カナダ: 引用元論文 508 件、この内訳の 4.1%フランス: 引用元論文 430 件、この内訳の 3.5%スペイン: 引用元論文 391 件、この内訳の 3.2%日本: 引用元論文 361 件、この内訳の 2.9%オーストラリア: 引用元論文 333 件、この内訳の 2.7%オランダ: 引用元論文 312 件、この内訳の 2.5%スイス: 引用元論文 300 件、この内訳の 2.4%
0%30.6%その他 21.3%

分野

  • Medicine50.7%
  • Biochemistry, Genetics and Molecular Biology45.1%
  • Computer Science1.5%
  • Immunology and Microbiology1.3%
  • Agricultural and Biological Sciences0.3%
  • Chemistry0.3%
  • その他0.8%

トピック

  • Cancer Genomics and Diagnostics9.1%
  • Prostate Cancer Treatment and Research4.3%
  • Lung Cancer Treatments and Mutations3.8%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Ubiquitin and proteasome pathways2.1%
  • Genetic factors in colorectal cancer2.1%
  • その他75.9%

共著者

全論文

検索で開く
  1. OncoKB: A Precision Oncology Knowledge Base

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Omuro, Michael A. Postow, Dana E. Rathkopf, Alexander N. Shoushtari, Neerav Shukla, Martin H. Voss, Ederlinda Paraiso, Ahmet Zehir, Michael F. Berger, Barry S. Taylor, Leonard B. Saltz, Gregory J. Riely, Marc Ladanyi, David M. Hyman, José Baselga, Paul Sabbatini, David B. Solit, Nikolaus Schultz - JCO Precision Oncology 2017 被引用: 2,698

  2. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 被引用: 3,517

  3. The Molecular Taxonomy of Primary Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fadi Brimo, Christopher A. Bristow, Denise Brooks, Bradley M. Broom, Alan H. Bryce, Glenn J. Bubley, Eric Burks, Yaron S.N. Butterfield, M. Button, David Canes, Carlos Gilberto Carlotti, Rebecca Carlsen, Michel Carmel, Peter R. Carroll, Scott L. Carter, Richard W. Cartun, Brett S. Carver, June M. Chan, Matthew T. Chang, Yu Chen, Andrew D. Cherniack, Simone Chevalier, Lynda Chin, Juok Cho, Andy Chu, Eric Chuah, Sudha Chudamani, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Matthew R. Cooperberg, Niall M. Corcoran, Anthony J. Costello, Janet E. Cowan, Daniel Crain, Erin Curley, Kerstin A. David, John A. Demchok, Francesca Demichelis, Noreen Dhalla, Rajiv Dhir, Alexandre A. Doueik, Bettina F. Drake, Heidi Dvinge, Natalya Dyakova, Ina Felau, Martin L. Ferguson, Scott Frazer, Stephen J. Freedland, Yao Fu, Stacey Gabriel, Jianjiong Gao, Johanna Gardner, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Mark Gerstein, Gad Getz, Andrew K. Godwin, Anuradha Gopalan, Markus Graefen, Kiley Graim, Thomas Gribbin, Ranabir Guin, Manaswi Gupta, Angela Hadjipanayis, Syed Haider, Lucie Hamel, D. Neil Hayes, David I. Heiman ほか 212 名 - Cell 2015 被引用: 3,279

  4. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 被引用: 1,006

  5. Genome doubling shapes the evolution and prognosis of advanced cancers

    著者: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2018 被引用: 692

  6. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , İnanç Birol, Tom Bodenheimer, Jay Bowen, Reanne Bowlby, Christopher A. Bristow, Denise Brooks, Rebecca Carlsen, Colleen M. Cebulla, Matthew T. Chang, Andrew D. Cherniack, Lynda Chin, Juok Cho, Eric Chuah, Sudha Chudamani, Carrie Cibulskis, Kristian Cibulskis, Leslie Cope, Sarah E. Coupland, Ludmila Danilova, Timothy Defreitas, John A. Demchok, Laurence Desjardins, Noreen Dhalla, Bita Esmaeli, Ina Felau, Martin L. Ferguson, Scott Frazer, Stacey Gabriel, Julie M. Gastier‐Foster, Nils Gehlenborg, Mark Gerken, Jeffrey E. Gershenwald, Gad Getz, Ewan A. Gibb, Klaus Griewank, Elizabeth A. Grimm, D. Neil Hayes, Apurva M. Hegde, David I. Heiman, Carmen Helsel, Julian M. Hess, Katherine A. Hoadley, Shital Hobensack, Robert A. Holt, Alan P. Hoyle, Xin Hu, Carolyn M. Hutter, Martine J. Jager, Stuart R. Jefferys, Corbin D. Jones, Steven J.M. Jones, Cyriac Kandoth, Katayoon Kasaian, Jaegil Kim, Patrick K. Kimes, Melanie Kucherlapati, Raju Kucherlapati, Eric S. Lander, Michael S. Lawrence, Alexander J. Lazar, Semin Lee, Kristen Leraas, Tara M. Lichtenberg, Pei Lin, Jia Liu, Wenbin Liu, Laxmi Lolla, Yiling Lu, Lisa Iype, Yussanne Ma ほか 111 名 - Cancer Cell 2017 被引用: 919

  7. An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zora Modrušan, Richard Zang, Yi‐Chen Chen, Michał Kabza, Musaddeque Ahmed, Jason Li, Matthew T. Chang, Danilo Maddalo, Marie Evangelista, Xin Ye, James J. Crawford, Anwesha Dey - Nature Cancer 2023 被引用: 195

  8. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

    著者: , , , , , , , , , , , - Nature Biotechnology 2015 被引用: 832

  9. Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS

    著者: , , , , , , , , , , , , , , , , , , - Nature 2017 被引用: 562

  10. Accelerating Discovery of Functional Mutant Alleles in Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Neal Rosen, David B. Solit, David M. Hyman, Barry S. Taylor - Cancer Discovery 2017 被引用: 426

  11. Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles M. Rudin, David M. Hyman, Michael F. Berger, David B. Solit, Marc Ladanyi, Gregory J. Riely - Cancer Discovery 2017 被引用: 662

  12. Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2019 被引用: 295

  13. USP7 small-molecule inhibitors interfere with ubiquitin binding

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christiaan Klijn, Elizabeth Blackwood, Scott E. Martin, William F. Forrest, James A. Ernst, Chudi Ndubaku, Xiaojing Wang, Maureen H. Beresini, Vickie Tsui, Carsten Schwerdtfeger, Robert A. Blake, Jeremy Murray, Till Maurer, Ingrid E. Wertz - Nature 2017 被引用: 346

  14. ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoon-Hee Hong, Young Su Noh, Munjeong Choi, Oakpil Han, Małgorzata Nowicka, Shrividhya Srinivasan, Yibing Yan, Tae Won Kim, Shiva Malek - Nature 2021 被引用: 135

  15. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance

    著者: , , , - Nature Reviews Clinical Oncology 2017 被引用: 328

  16. AKT Inhibition in Solid Tumors With AKT1 Mutations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Baselga, Barry S. Taylor - Journal of Clinical Oncology 2017 被引用: 325

  17. Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma

    著者: , , , , , , , , , , , , , - Nature Genetics 2016 被引用: 312

  18. Copy number alteration burden predicts prostate cancer relapse

    著者: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 被引用: 387

  19. Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claudia M. Wever, Nathalie A. Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R. Flowers, Ingrid E. Wertz - American Journal of Hematology 2023 被引用: 26

  20. Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties

    著者: , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 被引用: 148

  21. Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 被引用: 131

  22. Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways

    著者: , , , , , , , , , , , , , , , , , - Cancer Discovery 2020 被引用: 63

  23. 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets

    著者: , , , , , , , , , , - Genome Medicine 2017 被引用: 233

  24. The Hippo Pathway as a Driver of Select Human Cancers

    著者: , , , , - Trends in cancer 2020 被引用: 79